Who Owns Quoin Pharmaceuticals Stock?
NASDAQ: QNRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 4.31 -4.16%
Ownership breakdown
- Held by institutions
- 27.75%
- Held by insiders
- 3.67%
- Institutional holders
- 23
- Institutions 27.8%
- Insiders 3.7%
- Public and other 68.6%
Who owns Quoin Pharmaceuticals stock?
Institutional investors own about 27.8% of Quoin Pharmaceuticals's shares, spread across 23 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 3.67% of QNRX.
The largest institutional holders are Dauntless Investment Group, LLC (10.70%), Ikarian Capital, LLC (10.53%) and Stonepine Capital Management, LLC (9.93%). Together, the top 10 institutions control 59.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their QNRX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of QNRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Dauntless Investment Group, LLC | 214.99K | 10.70% | +9.4% |
| Ikarian Capital, LLC | 211.54K | 10.53% | 0.0% |
| Stonepine Capital Management, LLC | 199.49K | 9.93% | +273.1% |
| Millennium Management Llc | 112.32K | 5.59% | +47.3% |
| Summittx Capital, L.P. | 100.30K | 4.99% | 0.0% |
| Woodline Partners LP | 76.45K | 3.81% | -3.9% |
| Aberdeen Group plc | 75.00K | 3.73% | 0.0% |
| Soleus Capital Management, L.P. | 72.73K | 3.62% | 0.0% |
| AIGH Capital Management LLC | 70.00K | 3.49% | +37.3% |
| Boothbay Fund Management, LLC | 59.84K | 2.98% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of QNRX
| Fund | Shares | % Held |
|---|---|---|
| abrdn World Healthcare Fund | 40.40K | 2.01% |
| abrdn Life Sciences Investors | 34.60K | 1.72% |
Frequently asked questions
Who is the largest shareholder of Quoin Pharmaceuticals?
Dauntless Investment Group, LLC is the largest institutional shareholder of QNRX, owning 10.70% of shares outstanding (214.99K shares) as of its latest 13F filing.
What percentage of Quoin Pharmaceuticals is owned by institutions?
Institutions own about 27.8% of QNRX shares and 28.8% of the public float.
How much of Quoin Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 3.67% of QNRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.